Need Help?

The epigenomic response of skeletal muscle in life-long high-level trained and untrained men and women after acute exercise

To investigate the influence of lifelong exercise training on the response of skeletal muscle to a bout of acute exercise we generated targeted epigenomic data from long-term endurance (8 men) and strength (8 men) trained individuals and healthy age-matched untrained controls (8 men). Skeletal muscle biopsies were taken from M. vastus lateralis before, directly after, and 3hrs following acute exercise. Control subjects completed one bout of acute endurance exercise and one bout of acute resistance exercise, separated by 4-8 weeks, athletes completed one bout in their respective form of sports. All 96 samples were used for DNA extraction and targeted library construction using a custom Twist Biosciences panel and following EM-methylation tranformation were sequenced (2x150bp paired end) on the Illumina NovaSeq 6000.

Request Access

Standard EGA DAA

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom the Data access committee at the Molecular Exercise Physiology group (hereinafter called DAC-MolFys) grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: DAC-MolFys and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. DAC-MolFys: Karolinska Institutet, Department for Physiology and Pharmacology, Stockholm, Sweden 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify DAC-MolFys within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify DAC-MolFys prior to any significant changes to the protocol for the Project. 14. The User Institution will notify DAC-MolFys as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. DAC-MolFys may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than DAC-MolFys. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Sweden and shall be subject to the exclusive jurisdiction of the Swedish courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006139 Transcriptome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000110331 bam 359.5 MB
EGAF50000110332 bam 374.7 MB
EGAF50000110333 bam 387.6 MB
EGAF50000110334 bam 405.3 MB
EGAF50000110335 bam 401.5 MB
EGAF50000110336 bam 336.7 MB
EGAF50000110337 bam 477.5 MB
EGAF50000110338 bam 499.5 MB
EGAF50000110339 bam 481.0 MB
EGAF50000110340 bam 272.4 MB
EGAF50000110341 bam 338.1 MB
EGAF50000110342 bam 374.5 MB
EGAF50000110343 bam 411.7 MB
EGAF50000110344 bam 408.8 MB
EGAF50000110345 bam 467.8 MB
EGAF50000110346 bam 496.8 MB
EGAF50000110347 bam 423.4 MB
EGAF50000110348 bam 343.9 MB
EGAF50000110349 bam 585.8 MB
EGAF50000110350 bam 487.3 MB
EGAF50000110351 bam 562.9 MB
EGAF50000110352 bam 520.7 MB
EGAF50000110353 bam 534.4 MB
EGAF50000110354 bam 567.5 MB
EGAF50000110355 bam 472.2 MB
EGAF50000110356 bam 339.8 MB
EGAF50000110357 bam 425.2 MB
EGAF50000110358 bam 391.6 MB
EGAF50000110359 bam 385.8 MB
EGAF50000110360 bam 382.1 MB
EGAF50000110361 bam 328.5 MB
EGAF50000110362 bam 513.8 MB
EGAF50000110363 bam 482.4 MB
EGAF50000110364 bam 448.4 MB
EGAF50000110365 bam 442.2 MB
EGAF50000110366 bam 346.3 MB
EGAF50000110367 bam 554.1 MB
EGAF50000110368 bam 713.6 MB
EGAF50000110369 bam 418.5 MB
EGAF50000110370 bam 337.4 MB
EGAF50000110371 bam 347.3 MB
EGAF50000110372 bam 376.5 MB
EGAF50000110373 bam 370.2 MB
EGAF50000110374 bam 388.3 MB
EGAF50000110375 bam 344.9 MB
EGAF50000110376 bam 363.2 MB
EGAF50000110377 bam 406.6 MB
EGAF50000110378 bam 430.1 MB
EGAF50000110379 bam 348.5 MB
EGAF50000110380 bam 397.8 MB
EGAF50000110381 bam 359.0 MB
EGAF50000110382 bam 367.8 MB
EGAF50000110383 bam 308.3 MB
EGAF50000110384 bam 295.6 MB
EGAF50000110385 bam 357.6 MB
EGAF50000110386 bam 372.5 MB
EGAF50000110387 bam 354.6 MB
EGAF50000110388 bam 420.5 MB
EGAF50000110389 bam 458.4 MB
EGAF50000110390 bam 402.7 MB
EGAF50000110391 bam 313.7 MB
EGAF50000110392 bam 492.2 MB
EGAF50000110393 bam 427.6 MB
EGAF50000110394 bam 306.3 MB
EGAF50000110395 bam 258.8 MB
EGAF50000110396 bam 324.1 MB
EGAF50000110397 bam 338.6 MB
EGAF50000110398 bam 370.2 MB
EGAF50000110399 bam 373.8 MB
EGAF50000110400 bam 336.2 MB
EGAF50000110401 bam 424.9 MB
EGAF50000110402 bam 386.1 MB
EGAF50000110403 bam 386.6 MB
EGAF50000110404 bam 362.7 MB
EGAF50000110405 bam 377.6 MB
EGAF50000110406 bam 330.5 MB
EGAF50000110407 bam 314.7 MB
EGAF50000110408 bam 273.7 MB
EGAF50000110409 bam 295.0 MB
EGAF50000110410 bam 308.1 MB
EGAF50000110411 bam 301.4 MB
EGAF50000110412 bam 385.7 MB
EGAF50000110413 bam 391.9 MB
EGAF50000110414 bam 372.9 MB
EGAF50000110415 bam 356.5 MB
EGAF50000110416 bam 295.7 MB
EGAF50000110417 bam 332.7 MB
EGAF50000110418 bam 285.7 MB
EGAF50000110419 bam 285.9 MB
EGAF50000110420 bam 326.8 MB
EGAF50000110421 bam 478.5 MB
EGAF50000110422 bam 404.7 MB
EGAF50000110423 bam 469.5 MB
EGAF50000110424 bam 290.0 MB
EGAF50000110425 bam 269.9 MB
EGAF50000110426 bam 317.7 MB
96 Files (37.5 GB)